{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:27:42Z","timestamp":1768465662882,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Epidemiology and Management"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.deman.2022.100122","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T15:09:58Z","timestamp":1669216198000},"page":"100122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The glycemic, cholesterol, and weight effects of L-carnitine in diabetes: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"10","author":[{"given":"Jennifer","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huyentran N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.C.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana X.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/joim.12071","article-title":"Ectopic lipid storage and insulin resistance: a harmful relationship","volume":"274","author":"Bor\u00e9n","year":"2013","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0002","first-page":"S45","article-title":"Carnitine and type 2 diabetes","volume":"25","author":"Mynatt","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.deman.2022.100122_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41387-018-0017-1","article-title":"Role of carnitine and its derivatives in the development and management of type 2 diabetes","volume":"8","author":"Bene","year":"2018","journal-title":"Nutr Diabetes"},{"issue":"3","key":"10.1016\/j.deman.2022.100122_bib0004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1389201033489829","article-title":"Vlassopoulos D. Carnitine metabolism and deficit\u2013when supplementation is necessary?","volume":"4","author":"Evangeliou","year":"2003","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"10.1016\/j.deman.2022.100122_bib0005","first-page":"E946","article-title":"Interaction of carnitine with insulin-stimulated glucose metabolism in humans","volume":"255","author":"Ferrannini","year":"1988","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.deman.2022.100122_bib0006","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0168-8227(91)90020-E","article-title":"Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients","volume":"14","author":"Capaldo","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/07315724.1999.10718830","article-title":"L-carnitine improves glucose disposal in type 2 diabetic patients","volume":"18","author":"Mingrone","year":"1999","journal-title":"J Am Coll Nutr"},{"issue":"2","key":"10.1016\/j.deman.2022.100122_bib0008","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/0115426505020002218","article-title":"Levocarnitine and dialysis: a review","volume":"20","author":"Schreiber","year":"2005","journal-title":"Nutr Clin Pract"},{"issue":"4","key":"10.1016\/j.deman.2022.100122_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0033-1333688","article-title":"Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis","volume":"121","author":"Vidal-Casariego","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"10.1016\/j.deman.2022.100122_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.deman.2022.100122_bib0011","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.deman.2022.100122_bib0012","unstructured":"Current version of RoB 2 2019: RoB2 Development Group; [Available from: https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2."},{"key":"10.1016\/j.deman.2022.100122_bib0013","unstructured":"Cochrane handbook for systematic reviews of interventions: The Cochrane Collaboration; [cited 2022 February 7]. Available from: https:\/\/handbook-5-1.cochrane.org\/chapter_7\/7_7_3_2_obtaining_standard_deviations_from_standard_errors_and.htm."},{"issue":"7414","key":"10.1016\/j.deman.2022.100122_bib0014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.deman.2022.100122_bib0015","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.17554\/j.issn.2224-3992.2016.05.662","article-title":"Evaluation of L-Carnitine efficacy in the treatment of non- alcoholic fatty liver disease among diabetic patients: a randomized double blind pilot study: Alavinejad P et al . L-Carnitine for management of NAFLD","volume":"5","author":"Alavinejad","year":"2016","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"8","key":"10.1016\/j.deman.2022.100122_bib0016","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1017\/S1047951121000226","article-title":"Comparative study of the efficacy of captopril, simvastatin, and L-carnitine as cardioprotective drugs in children with type 1 diabetes mellitus: a randomised controlled trial","volume":"31","author":"Badreldeen","year":"2021","journal-title":"Cardiol Young"},{"issue":"7","key":"10.1016\/j.deman.2022.100122_bib0017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/dc14-2852","article-title":"Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial","volume":"38","author":"Bae","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00044011-200222001-00004","article-title":"Effects of combined treatment with simvastatin and L-carnitine on triglyceride levels in diabetic patients with hyperlipidaemia","volume":"22","author":"Brescia","year":"2002","journal-title":"Clin Drug Investig"},{"issue":"5","key":"10.1016\/j.deman.2022.100122_bib0019","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0149-2918(03)80130-3","article-title":"The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"issue":"9","key":"10.1016\/j.deman.2022.100122_bib0020","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1507\/endocrj.K10E-049","article-title":"Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients","volume":"57","author":"Derosa","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.deman.2022.100122_bib0021","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2169\/internalmedicine.49.3401","article-title":"Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients","volume":"49","author":"Derosa","year":"2010","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.dsx.2018.08.035","article-title":"Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients","volume":"13","author":"El-Sheikh","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"12","key":"10.1016\/j.deman.2022.100122_bib0023","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1517\/14656560903081745","article-title":"Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus","volume":"10","author":"Galvano","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.deman.2022.100122_bib0024","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000151488","article-title":"Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients","volume":"52","author":"Gonz\u00e1lez-Ortiz","year":"2008","journal-title":"Ann Nutr Metab"},{"issue":"11","key":"10.1016\/j.deman.2022.100122_bib0025","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.metabol.2009.05.014","article-title":"Effect of l-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin","volume":"58","author":"Malaguarnera","year":"2009","journal-title":"Metab Clin Exp"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0026","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3945\/ajcn.2008.26251","article-title":"L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes","volume":"89","author":"Malaguarnera","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.deman.2022.100122_bib0027","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/js.2017-00426","article-title":"Blood pressure and metabolic effects of acetyl-l-carnitine in type 2 diabetes: DIABASI randomized controlled trial","volume":"2","author":"Parvanova","year":"2018","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.deman.2022.100122_bib0028","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.ejcn.1602109","article-title":"Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus","volume":"59","author":"Rahbar","year":"2005","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/j.deman.2022.100122_bib0029","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.atherosclerosis.2005.11.024","article-title":"Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus","volume":"188","author":"Solfrizzi","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.deman.2022.100122_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2020.101243","article-title":"Effects of L-carnitine supplementation on oxidative and metabolic status in patients with type 2 diabetes mellitus: A randomized, double-blind, clinical trial","volume":"40","author":"Talenezhad","year":"2020","journal-title":"Eur J Integr Med"},{"key":"10.1016\/j.deman.2022.100122_bib0031","doi-asserted-by":"crossref","DOI":"10.17795\/jhealthscope-14615","article-title":"Effect of L-carnitine supplementation on metabolic status in obese diabetic women with hypocaloric diet","volume":"3","author":"Alipour","year":"2014","journal-title":"Health Scope"},{"issue":"4","key":"10.1016\/j.deman.2022.100122_bib0032","doi-asserted-by":"crossref","first-page":"246","DOI":"10.34172\/jcvtr.2020.43","article-title":"The effects of L-carnitine supplementation on lipid concentrations inpatients with type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials","volume":"12","author":"Asbaghi","year":"2020","journal-title":"J Cardiovasc Thorac Res"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0033","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4239\/wjd.v6.i1.8","article-title":"Insulin sensitivity and complications in type 1 diabetes: new insights","volume":"6","author":"Bjornstad","year":"2015","journal-title":"World J Diabetes"},{"issue":"12","key":"10.1016\/j.deman.2022.100122_bib0034","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.metabol.2015.09.002","article-title":"Insulin resistance in type 1 diabetes mellitus","volume":"64","author":"Kaul","year":"2015","journal-title":"Metab Clin Exp"},{"issue":"8","key":"10.1016\/j.deman.2022.100122_bib0035","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/dc09-1727","article-title":"The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis","volume":"33","author":"Sherifali","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.deman.2022.100122_bib0036","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890.2011.560181","article-title":"A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials","volume":"44","author":"Musso","year":"2012","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.deman.2022.100122_bib0037","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-159-4-201308200-00007","article-title":"Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis","volume":"159","author":"Vasilakou","year":"2013","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.deman.2022.100122_bib0038","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jdiacomp.2015.07.011","article-title":"Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2years","volume":"29","author":"Liu","year":"2015","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.deman.2022.100122_bib0039","first-page":"631","article-title":"The effects of L-carnitine supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Fathizadeh","year":"2019","journal-title":"Excli J"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000345759","article-title":"Similarities in serum acylcarnitine patterns in type 1 and type 2 diabetes mellitus and in metabolic syndrome","volume":"62","author":"Bene","year":"2013","journal-title":"Ann Nutr Metab"},{"issue":"9","key":"10.1016\/j.deman.2022.100122_bib0041","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"Reuter","year":"2012","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0042","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-131-1-199907060-00006","article-title":"Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes","volume":"131","year":"1999","journal-title":"Ann Internal Med"},{"issue":"1","key":"10.1016\/j.deman.2022.100122_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145730","article-title":"Postprandial hypertriglyceridemia predicts development of insulin resistance glucose intolerance and type 2 diabetes","volume":"11","author":"Aslam","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.deman.2022.100122_bib0044","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/obr.12436","article-title":"The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Pooyandjoo","year":"2016","journal-title":"Obes Rev"},{"issue":"9","key":"10.1016\/j.deman.2022.100122_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092795","article-title":"L-Carnitine's effect on the biomarkers of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Choi","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.deman.2022.100122_bib0046","unstructured":"Rebouche CJ. Modern nutrition in health and disease. 2014."}],"container-title":["Diabetes Epidemiology and Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666970622000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666970622000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:22:04Z","timestamp":1763018524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666970622000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":46,"alternative-id":["S2666970622000725"],"URL":"https:\/\/doi.org\/10.1016\/j.deman.2022.100122","relation":{},"ISSN":["2666-9706"],"issn-type":[{"value":"2666-9706","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The glycemic, cholesterol, and weight effects of L-carnitine in diabetes: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Diabetes Epidemiology and Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.deman.2022.100122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"100122"}}